Inventor
WITTE ALISON
US22 patents
⚠️ This page may combine multiple inventors who share the name “WITTE ALISON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SQUIBB & SONS LLC
5 patentsUS9631025B2Apr 25, 2017
Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies
SQUIBB & SONS LLC11 citations83
US9138475B2Sep 22, 2015
Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies
SQUIBB & SONS LLC12 citations83
US9499632B2Nov 22, 2016
Human antibodies that bind CD22 and uses thereof
SQUIBB & SONS LLC8 citations82
US11072664B2Jul 27, 2021
Interferon receptor 1 antibodies and their uses
SQUIBB & SONS LLC3 citations73
US10385133B2Aug 20, 2019
Interferon receptor 1 antibodies and their uses
SQUIBB & SONS LLC2 citations73
MEDAREX INC
4 patentsUS7662381B2Feb 16, 2010
Interferon alpha receptor 1 antibodies and their uses
MEDAREX INC47 citations98
US8383118B2Feb 26, 2013
Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1
MEDAREX INC24 citations92
US7741449B2Jun 22, 2010
Anti-interferon alpha antibodies
MEDAREX INC19 citations92
US9453077B2Sep 27, 2016
Interferon receptor 1 antibodies and their uses
MEDAREX INC3 citations73
BRISTOL MYERS SQUIBB CO
3 patentsUS8945553B2Feb 3, 2015
Bispecific antibodies to IL-23 and IL-17A/F
BRISTOL MYERS SQUIBB CO16 citations91
US9783606B2Oct 10, 2017
Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies
BRISTOL MYERS SQUIBB CO1 citations61
US10358490B2Jul 23, 2019
Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies
BRISTOL MYERS SQUIBB CO0 citations51